Results 31 to 40 of about 344 (178)

Cannabinoids in hyperhidrosis

open access: yesJournal of Dermatological Treatment, 2022
Hyperhidrosis can significantly curtail patient quality of life, from debilitating physical symptoms to social stigmatization and reduced life opportunities. Current treatments often prove unsatisfactory, especially in sufferers of generalized hyperhidrosis.
Till Kaemmerer   +4 more
openaire   +3 more sources

Overview of Four Prescription Monitoring/Review Programs in Canada

open access: yesPain Research and Management, Volume 19, Issue 2, Page 102-106, 2014., 2014
BACKGROUND: Prescription monitoring or review programs collect information about prescription and dispensing of controlled substances for the purposes of monitoring, analysis and education. In Canada, it is the responsibility of the provincial institutions to organize, maintain and run such programs.
Andrea D Furlan   +6 more
wiley   +1 more source

Cannabinoids and Pain [PDF]

open access: yesPain Research and Management, 2001
Cannabinoids have been used to treat pain for many centuries. However, only during the past several decades have rigorous scientific methods been applied to understand the mechanisms of cannabinoid action. Cannabinoid receptors were discovered in the late 1980s and have been found to mediate the effects of cannabinoids on the nervous system.
J Michael Walker   +2 more
openaire   +3 more sources

Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society

open access: yesPain Research and Management, Volume 19, Issue 6, Page 328-335, 2014., 2014
BACKGROUND: Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease of the somatosensory system, is a disabling condition that affects approximately two million Canadians. OBJECTIVE: To review the randomized controlled trials (RCTs) and systematic reviews related to the pharmacological management of NeP to develop a revised evidence ...
DE Moulin   +17 more
wiley   +1 more source

Pharmacogenetics of Cannabinoids [PDF]

open access: yesEuropean Journal of Drug Metabolism and Pharmacokinetics, 2017
Although the application of medical marijuana and cannabinoid drugs is controversial, it is a part of modern-day medicine. The list of diseases in which cannabinoids are promoted as a treatment is constantly expanding. Cases of significant improvement in patients with a very poor prognosis of glioma or epilepsy have already been described. However, the
Hryhorowicz, Szymon   +4 more
openaire   +2 more sources

Alternative Targets Within the Endocannabinoid System for Future Treatment of Gastrointestinal Diseases

open access: yesCanadian Journal of Gastroenterology and Hepatology, Volume 25, Issue 7, Page 377-383, 2011., 2011
Many beneficial effects of herbal and synthetic cannabinoids on gut motility and inflammation have been demonstrated, suggesting a vast potential for these compounds in the treatment of gastrointestinal disorders. These effects are based on the so‐called ‘endocannabinoid system’ (ECS), a cooperating network of molecules that regulate the metabolism of ...
Rudolf Schicho, Martin Storr
wiley   +1 more source

Evaluación de la solución nutritiva Steiner aplicada al cultivo de cáñamo medicinal (Cannabis sativa L.) var. Cherry Oregon, bajo invernadero

open access: yesSiembra
El adecuado manejo nutricional es crucial para el desarrollo y producción de cannabinoides en el cultivo de Cannabis sativa var. Cherry Oregon. Esta investigación tuvo por objetivo evaluar el efecto de cinco concentraciones de solución nutritiva Steiner
Michelle Arcos   +5 more
doaj   +1 more source

Mariguana y sus efectos sobre el cerebro, la toma de decisiones y la inteligencia. Una revisión narrativa

open access: yesRevista Internacional de Investigación en Adicciones, 2016
Introduction: marijuana or cannabis is the most consumed drug after tobacco and alcohol, even in the condition that to carry more than a given amount is a crime, suggesting that cannabis consumers are highly motivated to get the drug.
Alejandra E. Ruiz Contreras   +4 more
doaj   +1 more source

Nightmares and the Cannabinoids [PDF]

open access: yesCurrent Neuropharmacology, 2020
:The cannabinoids, Δ9 tetrahydrocannabinol and its analogue, nabilone, have been found to reliably attenuate the intensity and frequency of post-traumatic nightmares. This essay examines how a traumatic event is captured in the mind, after just a single exposure, and repeatedly replicated during the nights that follow.
openaire   +2 more sources

Revisión sistemática de la literatura: tratamiento del dolor central en esclerosis múltiple

open access: yesActa Neurológica Colombiana, 2023
INTRODUCCIÓN: el dolor es un síntoma muy común en pacientes con Esclerosis Múltiple (EM), 42 al 65 por ciento de los enfermos lo presentan, y es calificado como el síntoma más severo entre el 8 y el 32 por ciento. Todos los síndromes dolorosos centrales
Diana Patricia Correa Castillo   +1 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy